69 Biggest Movers From Friday
Gainers
Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Homology Medicines Received FDA Orphan Drug Approval For Recombinant Adeno-associated Viral Vector Serotype HSC15 For Treatment Of Phenylalanine Hydroxylase Deficiency
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=879022
Homology Medicines Highlights Presentation Of Optimized HMI-103 Nuclease-Free Gene Editing Candidate At SGCT Annual Meeting
- Additional Data at ASGCT Annual Meeting Demonstrate Precision of HR-Based Approach with Genome-Wide Integration Assays Confirming On-Target Editing and No Off-Target Events -
- New Data from GTx-mAb Platform Support
Analyst Ratings for Homology Medicines
Within the last quarter, Homology Medicines (NASDAQ:FIXX) has observed the following analyst ratings:
Homology Medicines Highlights Upcoming Presentation On Optimized In Vivo Gene Editing Candidate HMI-103 At American Society for Gene & Cell Therapy
- Multiple Presentations Feature HMI-103 Phase 1 Investigational Therapy for PKU, Including Genome-Wide Integration Assays to Confirm No Off-Target Editing -
- New Data from GTx-mAb Program Support Potential to Target
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.